Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone214-937-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$453.04 million
Profitability
Miscellaneous
Employees954
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable
Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions
What is Orthofix Medical's stock symbol?
Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
How were Orthofix Medical's earnings last quarter?
Orthofix Medical Inc (NASDAQ:OFIX) announced its quarterly earnings data on Monday, August, 5th. The medical device company reported $0.28 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.40 by $0.12. The medical device company earned $115.85 million during the quarter, compared to analyst estimates of $115.17 million. Orthofix Medical had a net margin of 1.75% and a return on equity of 9.50%. The company's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.42 earnings per share. View Orthofix Medical's Earnings History.
When is Orthofix Medical's next earnings date?
What guidance has Orthofix Medical issued on next quarter's earnings?
Orthofix Medical updated its FY19 earnings guidance on Monday, August, 5th. The company provided earnings per share guidance of $1.75-1.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.78. The company issued revenue guidance of $472-477 million, compared to the consensus revenue estimate of $473.70 million.
What price target have analysts set for OFIX?
2 Wall Street analysts have issued 12-month price targets for Orthofix Medical's stock. Their predictions range from $60.00 to $60.00. On average, they anticipate Orthofix Medical's stock price to reach $60.00 in the next twelve months. This suggests a possible upside of 17.7% from the stock's current price. View Analyst Price Targets for Orthofix Medical.
What is the consensus analysts' recommendation for Orthofix Medical?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.
Has Orthofix Medical been receiving favorable news coverage?
News stories about OFIX stock have been trending somewhat positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orthofix Medical earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned news headlines about the medical device company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Orthofix Medical.
Who are some of Orthofix Medical's key competitors?
Some companies that are related to Orthofix Medical include Tandem Diabetes Care (TNDM), Cantel Medical (CMD), NuVasive (NUVA), ICU Medical (ICUI), Nevro (NVRO), Glaukos (GKOS), Irhythm Technologies (IRTC), Cardiovascular Systems (CSII), Merit Medical Systems (MMSI), Atrion (ATRI), Silk Road Medical (SILK), Cryolife (CRY), Luminex (LMNX), Tactile Systems Technology (TCMD) and AtriCure (ATRC).
What other stocks do shareholders of Orthofix Medical own?
Who are Orthofix Medical's key executives?
Orthofix Medical's management team includes the folowing people:
- Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
- Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
- Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
- Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
- Mr. Davide Bianchi, Pres of Global Extremities (Age 54)
Who are Orthofix Medical's major shareholders?
Orthofix Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.92%), Vanguard Group Inc. (10.37%), Renaissance Technologies LLC (3.00%), Nuveen Asset Management LLC (2.25%), Victory Capital Management Inc. (2.19%) and Oakview Capital Management L.P. (2.14%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.
Which major investors are selling Orthofix Medical stock?
OFIX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Charles Schwab Investment Management Inc., Invesco Ltd., First Trust Advisors LP, Acadian Asset Management LLC, Russell Investments Group Ltd., BlackRock Inc. and SG Americas Securities LLC. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick and Rice Doug. View Insider Buying and Selling for Orthofix Medical.
Which major investors are buying Orthofix Medical stock?
OFIX stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Dalton Greiner Hartman Maher & Co., THB Asset Management, Oakview Capital Management L.P., Marshall Wace LLP, Morgan Stanley, D. E. Shaw & Co. Inc. and Vanguard Group Inc.. View Insider Buying and Selling for Orthofix Medical.
How do I buy shares of Orthofix Medical?
Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Orthofix Medical's stock price today?
One share of OFIX stock can currently be purchased for approximately $50.99.
How big of a company is Orthofix Medical?
Orthofix Medical has a market capitalization of $972.38 million and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.
What is Orthofix Medical's official website?
How can I contact Orthofix Medical?
Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]
MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
